Royal Bank of Canada’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29K | Buy |
4,217
+1,656
| +65% | +$11.4K | ﹤0.01% | 5759 |
|
|
2025
Q1 | $7K | Sell |
2,561
-3,266
| -56% | -$8.93K | ﹤0.01% | 5871 |
|
|
2024
Q4 | $28K | Sell |
5,827
-415
| -7% | -$1.99K | ﹤0.01% | 5475 |
|
|
2024
Q3 | $22K | Buy |
6,242
+298
| +5% | +$1.05K | ﹤0.01% | 5604 |
|
|
2024
Q2 | $37K | Buy |
5,944
+5,936
| +74,200% | +$37K | ﹤0.01% | 5397 |
|
|
2024
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 6674 |
|
|
2023
Q4 | $0 | Sell |
8
-2
| -20% | – | ﹤0.01% | 6695 |
|
|
2023
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 6704 |
|
|
2023
Q2 | $0 | Sell |
10
-2,884
| -100% | – | ﹤0.01% | 6888 |
|
|
2023
Q1 | $8K | Sell |
2,894
-4,757
| -62% | -$13.2K | ﹤0.01% | 6017 |
|
|
2022
Q4 | $56K | Buy |
7,651
+7,216
| +1,659% | +$52.8K | ﹤0.01% | 5341 |
|
|
2022
Q3 | $3K | Buy |
435
+235
| +118% | +$1.62K | ﹤0.01% | 6394 |
|
|
2022
Q2 | $1K | Sell |
200
-1,496
| -88% | -$7.48K | ﹤0.01% | 6653 |
|
|
2022
Q1 | $40K | Sell |
1,696
-2,887
| -63% | -$68.1K | ﹤0.01% | 5753 |
|
|
2021
Q4 | $81K | Buy |
4,583
+1,343
| +41% | +$23.7K | ﹤0.01% | 5550 |
|
|
2021
Q3 | $91K | Buy |
3,240
+1,722
| +113% | +$48.4K | ﹤0.01% | 5260 |
|
|
2021
Q2 | $16K | Sell |
1,518
-168
| -10% | -$1.77K | ﹤0.01% | 6171 |
|
|
2021
Q1 | $20K | Buy |
1,686
+990
| +142% | +$11.7K | ﹤0.01% | 5923 |
|
|
2020
Q4 | $8K | Buy |
696
+673
| +2,926% | +$7.74K | ﹤0.01% | 5921 |
|
|
2020
Q3 | $0 | Buy |
23
+2
| +10% | – | ﹤0.01% | 6193 |
|
|
2020
Q2 | $0 | Sell |
21
-32
| -60% | – | ﹤0.01% | 6192 |
|
|
2020
Q1 | $1K | Sell |
53
-395
| -88% | -$7.45K | ﹤0.01% | 5922 |
|
|
2019
Q4 | $7K | Buy |
448
+162
| +57% | +$2.53K | ﹤0.01% | 5645 |
|
|
2019
Q3 | $2K | Buy |
+286
| New | +$2K | ﹤0.01% | 5615 |
|